Strongest evidence: The only outcome with moderate evidence strength is increased carnosine levels. All 3 studies reported beneficial effects, with effect sizes ranging from small to large. The most robust trial (RCT in COPD patients) found a large increase of +2.82 mmol/kg wet weight (p < 0.001) at 3.2 g/day over 84 days. Notably, effects typically require 8–12 weeks of supplementation. No other outcome reached moderate or high evidence strength.
Mixed or weaker evidence: Several outcomes have low or very low evidence strength. For physical performance (4 studies), only 2 of 4 reported beneficial small effects, with mixed results—half of studies were neutral. Heart rate reduction (5 studies) and lactate reduction (3 studies) both showed predominantly neutral findings, with no consistent benefits. Body fat mass, body mass, and rating of perceived exertion (RPE) each had 3 studies all reporting neutral effects, with no statistically significant results. The evidence for these outcomes is preliminary and insufficient to draw firm conclusions.
Effective dose patterns: The most consistent effective dose across positive evidence is 3.2 g/day for carnosine elevation. For other outcomes where an effective dose was noted (e.g., heart rate at 6.4 g/day, RPE at 6.4 g/day or a loading protocol of 5 g four times daily), the evidence is weak or neutral. No single dose range has been confirmed across multiple outcomes.
Population insights: The strongest evidence comes from clinical populations (COPD patients) and combat athletes. For weaker outcomes, study populations included athletes (e.g., cyclists, military personnel, basketball players). There is insufficient data to identify specific populations that benefit more than others, except that carnosine increases have been consistently shown in the few populations studied.
Notable caveats: The evidence base across all outcomes is small (3–5 studies each), making conclusions preliminary. Publication bias may inflate positive results—particularly for carnosine. Many studies lacked statistical significance (e.g., only 2 of 4 physical performance studies reached significance; none of the 3 body fat mass studies did). Dosing and duration varied widely, and several studies did not report full dosing details. Short durations (median 7–28 days for most outcomes) may be insufficient for beta-alanine to exert effects, as it typically requires weeks to elevate carnosine levels.